Patients with idiopathic inflammatory myopathies suffer from worse self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort-Reference-Cited by-同舟云学术

Patients with idiopathic inflammatory myopathies suffer from worse self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort

Published:2022-05-14 Issue:7 Volume:41 Page:2269-2272
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Kharbanda Rajat^ORCID,Ganatra Keya^ORCID,Abbasi Maryam^ORCID,Agarwal Vikas^ORCID,Gupta Latika^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-022-06204-0.pdf

Reference7 articles.

1. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, COVID-19 Global Rheumatology Alliance (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79(7):859–866. https://doi.org/10.1136/annrheumdis-2020-217871

2. Naveen R, Anuja A, Rai M et al (2020) Development of the MyoCite biobank: cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis. Indian J Rheumatol 15(6):194–199. https://doi.org/10.4103/injr.injr_95_20

3. Naveen R, Thakare DR, Agarwal V et al (2022) Validation of two simple patient-centered outcome measures for virtual monitoring of patients with idiopathic inflammatory myositis. Clin Rheumatol 41:765–772. https://doi.org/10.1007/s10067-021-05990-3

4. Saygin D, Oddis CV, Dzanko S, Koontz D, Moghadam-Kia S, Ardalan K, Coles TM, Aggarwal R (2021) Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy. Semin Arthritis Rheum 51(3):539–546. https://doi.org/10.1016/j.semarthrit.2021.03.018

5. Wohlfahrt A, Bingham CO 3rd, Marder W, Phillips K, Bolster MB, Moreland LW, Zhang Z, Neogi T, Lee YC (2019) Responsiveness of patient-reported outcomes measurement information system measures in rheumatoid arthritis patients starting or switching a disease-modifying antirheumatic drug. Arthritis Care Res 71(4):521–529. https://doi.org/10.1002/acr.23617

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study;International Journal of Rheumatic Diseases;2023-11-15

2. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study;Rheumatology International;2023-06-23

3. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys;Rheumatology;2023-04-21

4. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study;Rheumatology;2023-04-02

5. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys;Rheumatology;2023-02-03